Our patient at risk from unauthorized, unapproved, illegally imported fake “generic medicines”
Indian J Med Sci
;
2018 SEP; 70(3): 43-47
Artículo
| IMSEAR
| ID: sea-196507
ABSTRACT
Introduction:
We came across patients inquiring with oncologists about cheap copy medicines. These were of recently licensedinnovator drugs that should have been available from original company holding their patents. In fact these copy medicines weremanufactured in our neighboring countries and made available in India. We investigated further and this manuscript puts together thestartling information that we were able to find regarding the thriving grey market for fake generic medicines.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Tipo de estudio:
Estudio de etiología
Revista:
Indian J Med Sci
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS